Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0001193125-26-071503

SVP, CMO, Head-Res&Drug sold 17,012 shares at $3.66 ($62,264)

  • SVP, CMO, Head-Res&Drug sold 15,570 shares at $3.81 ($59,322)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shetzline Michael SVP, CMO, Head-Res&Drug 2026-02-23 Sale −15,570 $3.81 $59,322 538,437 D
Shetzline Michael SVP, CMO, Head-Res&Drug 2026-02-24 Sale +17,012 $3.66 $62,264 521,425 D
Open-market sales · 32,582 sh · avg $3.73 · $121,586
Loading xslF345X05/ownership.xml…